Despite high use of continuous glucose monitoring and insulin pump therapy, fear of hypoglycemia (low blood sugar) remains a significant barrier to physical activity and exercise for adults with type 1 diabetes (T1D), according to new research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).
Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million – Biotech Investments
Heidelberg Pharma AG / Key word(s): Financing Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million 04-March-2024 / 11:02